Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-03

Clinical Trial Update: Effect of Topical Dexmedetomidine on Intraocular Pressure [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating topical dexmedetomidine for reducing intraocular pressure in glaucoma patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Beirut Eye Specialist Hospital | Conditions: Glaucoma, Intraocular Pressure | Phase 4 | Status: COMPLETED